Article info

Download PDFPDF

Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix
Free

Authors

  • Omar Touhami Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Centre Intégré Universitaire de Santé et Services Sociaux CIUSSS du Saguenay-Lac-Saint-Jean, Sherbrooke University, Chicoutimi, Quebec, Canada PubMed articlesGoogle scholar articles
  • Marie Plante Gynecologic Oncology Division, CHU de Quebec, L'Hôtel-Dieu de Quebec, Laval University, Quebec City, Quebec, Canada PubMed articlesGoogle scholar articles
  • Jonathan St-Gelais Department of Hematology-Oncology, Centre Intégré Universitaire de Santé et Services Sociaux CIUSSS du Saguenay-Lac-Saint-Jean, Sherbrooke University, Chicoutimi, Quebec, Canada PubMed articlesGoogle scholar articles
  • Michael Frumovitz Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Omar Touhami, Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Centre Intégré Universitaire de Santé et Services Sociaux CIUSSS du Saguenay-Lac-Saint-Jean, Sherbrooke University, Chicoutimi, QC G1R 2J4, Canada; touhamiomar{at}yahoo.fr

Citation

Touhami O, Plante M, St-Gelais J, et al
Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix

Publication history

  • Accepted February 6, 2023
  • First published April 3, 2023.
Online issue publication 
April 03, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.